Megan Jennings, BS Bioengineering, UC San Diego (she/her/hers)

Janssen R&D, California, United States

Megan Jennings is a Principal Scientist and leader of the Johnson & Johnson Innovative Medicine (formerly Janssen R&D) Sample Logistics, Tissue Culture, and Automation teams in La Jolla, California. She began her career at Vertex Pharmaceuticals, Inc. implementing tissue culture automation to support screening and development of Kalydeco® (ivacaftor) before departing for Eli Lilly & Co.’s Biotechnology Discovery Research team. At Illumina, Inc. she led a Lab Automation team in the Factory of the Future organization to develop integrated manufacturing filling processes for the iSeq 100 and NextSeq 1000/2000 consumables cartridges before returning to R&D as part of the J&J Innovative Medicine team. Megan holds a degree in Bioengineering from the Jacobs School of Engineering at the University of California, San Diego.

Disclosure information not submitted.

Presentation(s):

• Enabling End-to-End Data and Sample Management Capabilities for siRNA molecules from Synthesis to Assay Data Submission

  Tuesday, February 6, 2024
  10:30 AM – 11:00 AM EST